Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biomed Pharmacother
2018 Oct 01;106:510-522. doi: 10.1016/j.biopha.2018.06.157.
Show Gene links
Show Anatomy links
Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker.
Walker MJA
,
Hayes ES
,
Saint DA
,
Adaikan G
,
Abraham S
,
Goldin AL
,
Beatch GN
,
MacLeod BA
,
Wall RA
,
Pugsley MK
.
???displayArticle.abstract???
BACKGROUND: RSD921, the R,R enantiomer of the kappa (k) agonist PD117,302, lacks significant activity on opioid receptors.
METHODS: The pharmacological and toxicological actions were studied with reference to cardiovascular, cardiac, antiarrhythmic, toxic and local anaesthetic activity.
RESULTS: In rats, dogs and baboons, RSD921 dose-dependently reduced blood pressure and heart rate. In a manner consistent with sodium channel blockade it prolonged the PR and QRS intervals of the ECG. Furthermore, in rats and NHP, RSD921 increased the threshold currents for induction of extra-systoles and ventricular fibrillation (VFt), and prolonged effective refractory period (ERP). In rats, RSD921 was protective against arrhythmias induced by electrical stimulation and coronary artery occlusion. Application of RSD921 to voltage-clamped rat cardiac myocytes blocked sodium currents. RSD921 also blocked transient (ito) and sustained (IKsus) outward potassium currents, albeit with reduced potency relative to sodium current blockade. Sodium channel blockade due to RSD921 in myocytes and isolated hearts was enhanced under ischaemic conditions (low pH and high extracellular potassium concentration). When tested on the cardiac, neuronal and skeletal muscle forms of sodium channels expressed in Xenopus laevis oocytes, RSD921 produced equipotent tonic block of sodium currents, enhanced channel block at reduced pH (6.4) and marked use-dependent block of the cardiac isoform. RSD921 had limited but quantifiable effects in subacute toxicology studies in rats and dogs. Pharmacokinetic analyses were performed in baboons. Plasma concentrations producing cardiac actions in vivo after intravenous administration of RSD921 were similar to the concentrations effective in the in vitro assays utilized.
CONCLUSIONS: RSD921 primarily blocks sodium currents, and possesses antiarrhythmic and local anaesthetic activity.
Alpert,
Is there a second external lidocaine binding site on mammalian cardiac cells?
1989, Pubmed
Alpert,
Is there a second external lidocaine binding site on mammalian cardiac cells?
1989,
Pubmed
BULBRING,
Observations on the isolated phrenic nerve diaphragm preparation of the rat.
1946,
Pubmed
Balser,
Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone.
1991,
Pubmed
Barber,
Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites.
1991,
Pubmed
Baumgarten,
External site for local anesthetic block of cardiac Na+ channels.
1991,
Pubmed
Beatch,
Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
1991,
Pubmed
Beatch,
Effects of optical enantiomers CK-4000(S) and CK-4001(R) on defibrillation and enhancement of shock-induced extension of action potential duration.
1995,
Pubmed
Boachie-Ansah,
The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.
1989,
Pubmed
Botting,
Arrhythmias associated with myocardial ischaemia and infarction.
1985,
Pubmed
Clark,
Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives.
1988,
Pubmed
Clark,
PD117302: a selective agonist for the kappa-opioid receptor.
1988,
Pubmed
Clark,
Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size.
1980,
Pubmed
Courtney,
Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA.
1975,
Pubmed
Curtis,
The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias.
2013,
Pubmed
Curtis,
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers.
2018,
Pubmed
Curtis,
Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia.
1988,
Pubmed
Curtis,
An improved perfusion apparatus for small animal hearts.
1986,
Pubmed
Fagbemi,
Naloxone inhibits early arrhythmias resulting from acute coronary ligation.
1982,
Pubmed
Fagbemi,
Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia.
1983,
Pubmed
Grant,
The influence of pH on th electrophysiological effects of lidocaine in guinea pig ventricular myocardium.
1980,
Pubmed
Halfpenny,
Highly selective kappa-opioid analgesics. 2. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide derivatives.
1989,
Pubmed
Harasawa,
Inhibitory effect of spiradoline, a kappa opioid receptor agonist, on Ca2+ induced contraction and the intracellular Ca2+ concentration in porcine coronary artery.
1991,
Pubmed
Hille,
Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.
1977,
Pubmed
Hondeghem,
Antiarrhythmic agents: modulated receptor applications.
1987,
Pubmed
Hondeghem,
Antiarrhythmic drug action: selective depression of hypoxic cardiac cells.
1974,
Pubmed
Howard,
Electrical stimulation studies with quinacainol, a putative 1C agent, in the anaesthetised rat.
1990,
Pubmed
Hughes,
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.
1972,
Pubmed
Illes,
Beta-endorphin-sensitive opioid receptors in the rat tail artery.
1987,
Pubmed
Johnston,
Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics.
1983,
Pubmed
Josephson,
Early outward current in rat single ventricular cells.
1984,
Pubmed
Kilkenny,
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.
2010,
Pubmed
Lee,
Consequences of opiate agonist and antagonist in myocardial ischaemia suggest a role of endogenous opioid peptides in ischaemic heart disease.
1992,
Pubmed
Leighton,
Pharmacological profile of PD 117302, a selective kappa-opioid agonist.
1987,
Pubmed
Leszczynska,
A sciatic nerve blockade method to differentiate drug-induced local anesthesia from neuromuscular blockade in mice.
1992,
Pubmed
MacLean,
Effect of artificial respiratory volume on the cardiovascular responses to an alpha 1- and an alpha 2-adrenoceptor agonist in the air-ventilated pithed rat.
1988,
Pubmed
Meecham,
An in vitro profile of activity for the (+) and (-) enantiomers of spiradoline and PD117302.
1989,
Pubmed
Narahashi,
The site of action and active form of local anesthetics. I. Theory and pH experiments with tertiary compounds.
1970,
Pubmed
Nattel,
Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.
1991,
Pubmed
Paletta,
Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats.
1989,
Pubmed
Parratt,
Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischaemia.
1986,
Pubmed
Penz,
A new ECG measure (RSh) for detecting possible sodium channel blockade in vivo in rats.
1992,
Pubmed
Pugsley,
Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921.
1999,
Pubmed
,
Xenbase
Pugsley,
U-50,488H, a kappa opioid receptor agonist, is a more potent blocker of cardiac sodium channels than lidocaine.
2000,
Pubmed
,
Xenbase
Pugsley,
Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion.
1992,
Pubmed
Pugsley,
Do related kappa agonists produce similar effects on cardiac ion channels?
1995,
Pubmed
Pugsley,
An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
1994,
Pubmed
Pugsley,
Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.
1993,
Pubmed
Sagy,
Nonopiate effect of naloxone on cardiac muscle contractility.
1987,
Pubmed
Saint,
A persistent sodium current in rat ventricular myocytes.
1992,
Pubmed
Sarne,
Anti-arrhythmic activities of opioid agonists and antagonists and their stereoisomers.
1991,
Pubmed
Sarne,
Antiarrhythmic action of naloxone: direct, non-opiate effect on the rat heart.
1988,
Pubmed
Sitsapesan,
The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia.
1989,
Pubmed
Strichartz,
The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine.
1973,
Pubmed
Walker,
Electrically induced arrhythmias in the rat.
1988,
Pubmed
Walker,
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion.
1988,
Pubmed
Walker,
Determination of an arylacetamide antiarrhythmic in rat blood and tissues using reversed-phase high-performance liquid chromatography.
1996,
Pubmed
Watson,
Effect of intracellular and extracellular acidosis on sodium current in ventricular myocytes.
1995,
Pubmed
Wolzt,
Is the ECG measure RSh a promising technique for detecting class I antiarrhythmic drug action in men?
1995,
Pubmed
Wong,
Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart--an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis.
1990,
Pubmed
